Tumor differentiation in breast carcinomas with a novel physical method

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00012767

Enrollment

150

Registered

2018-07-02

Start date

2017-07-20

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C50

Interventions

Group 1: Patients with breast cancer (tumor size = 20 mm). Tumor tissue will be treated with a new physical-optical method and a differentiation shall be assessed between benign vs. malignant tissue.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Mammacarcinoma = 20mm, all histological types, signed informed consent

Exclusion criteria

Exclusion criteria: Age < 18 years

Design outcomes

Primary

Measure	Time frame
Aim of this study is to prove the possibility of using a physical-optical method form tumor differentiation	—

Countries

Germany

Contacts

Public ContactMarkus Hahn

Department für Frauengesundheit

kontakt@uni-frauenklinik-tuebingen.de07071-29-82211

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026